Curcumin extract improves beta cell functions in obese patients with type 2 diabetes: a randomized controlled trial.

ABSTRACT:

Background

Type 2 diabetes mellitus (T2DM) is a chronic condition characterized by insulin resistance and impaired insulin production, leading to elevated blood glucose levels. Curcumin, a polyphenolic compound from Curcuma longa, has shown potential in improving insulin sensitivity and reducing blood glucose levels, which may help mitigate type 2 diabetes progression.

Objective

To assess the efficacy of improving type 2 diabetes (T2DM).

Study design

This randomized, double-blind, placebo-controlled trial included subjects (n = 272) with criteria for type 2 diabetes.

Methods

All subjects were randomly assigned to receive curcumin (1500 mg/day) or placebo with blind labels for 12 months. To assess the improvement of T2DM after curcumin treatments body weight and

SUBMITTER: Yaikwawong M 

PROVIDER: S-EPMC11445938 | biostudies-literature | 2024 Oct

REPOSITORIES: biostudies-literature